Clinical Trials Browser

Phase 2 × pegylated granulocyte colony-stimulating factor, human × Clear all

NCT05645718 2025-10-07

Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic Leukemia

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia

NCT00671658 2020-12-03

Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic Leukemia

Phase 2 Completed

220 enrolled 6 charts

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00101010 2020-10-19

Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma

Phase 2 Completed

80 enrolled 7 charts

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT00069953 2017-02-17

Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Phase 2 Completed

43 enrolled 5 charts

Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT03045627 2017-02-07

Clinical Trial of Ara-C, Aclarubicin Combined With PEG-G-CSF for Initial Treatment of AML Patients

Phase 2 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT01923545 2014-10-01

PEG-G-CSF

Phase 2 Completed

Chemotherapy Induced Neutropenia

NCT00067639 2012-08-01

Pegfilgrastim (Neulasta) for Stem Cell Mobilization in Patients With Multiple Myeloma

Phase 2 Completed

Multiple Myeloma